Al-Sawaf, O., Robrecht, S., Fink, A., Ritgen, M., Johansson, P., Staber, P., Jaeger, U., Niemann, C., Pallasch, C., Kreuzer, K., Stilgenbauer, S., Fischer, K., Wendtner, C., Hallek, M. and Eichhorst, B. (2020). The CLL-RT1 trial: A multi-center phase-2 trial to evaluate the efficacy and safety of zanubrutinib, a BTK inhibitor, plus tislelizumab, a PD-1 inhibitor, for treatment of patients with Richter Transformation. Oncol. Res. Treat., 43 (SUPPL 4). S. 73 - 74. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Al-Sawaf, O.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Robrecht, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fink, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ritgen, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Johansson, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Staber, P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jaeger, U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Niemann, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Pallasch, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kreuzer, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stilgenbauer, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fischer, K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wendtner, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hallek, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eichhorst, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-317229
Journal or Publication Title: Oncol. Res. Treat.
Volume: 43
Number: SUPPL 4
Page Range: S. 73 - 74
Date: 2020
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/31722

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item